华恒生物：上半年净利润1.15亿元，同比下降23.26%

Core Insights - The company reported a significant increase in revenue for the first half of 2025, achieving 1.489 billion yuan, which represents a year-on-year growth of 46.54% [1] - However, the net profit attributable to shareholders decreased to 115 million yuan, reflecting a decline of 23.26% compared to the previous year [1] - The basic earnings per share stood at 0.46 yuan [1]